Convergence of ocular organoids and microfluidic platforms for advanced disease modeling and drug screening: Next generation eye models
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Ocular Oncology and Treatments · Retinal Development and Disorders · Retinal Diseases and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. Magnitude, temporal trends, and projections of the global prevalence of blindness and distance and near vision impairment: a systematic review and meta-analysis10.1016/S2214-109X(17)30293-0 ↗
2. Global estimates of visual impairment: 201010.1136/bjophthalmol-2011-300539 ↗
3. Pathogenesis of common ocular diseases10.1155/2015/734527 ↗
4. Prevalence and risk factors of age-related macular degeneration in South Korea: korea national health and nutrition examination survey10.1080/09286586.2024.2321892 ↗
5. Colombian ocular diseases epidemiology study (CODES): prevalence and sociodemographic characterization of refractive errors in Colombian eye care consultations10.1080/09286586.2024.2330386 ↗
6. In vitro cell models for ophthalmic drug development applications10.1089/biores.2016.0008 ↗
7. Looking into the eyes—in vitro models for ocular research10.3390/ijms23169158 ↗
8. Animal and cellular models of microphthalmia
9. Establishment of vascularized human retinal organoids from induced pluripotent stem cells
10. Vascular endothelial growth factors and placenta growth factor in retinal vasculopathies: current research and future perspectives10.1016/j.cytogfr.2017.11.005 ↗
11. Microfluidic outer blood–retinal barrier model for inducing wet age-related macular degeneration by hypoxic stress10.1039/D2LC00672C ↗
12. Modeling early pathophysiological phenotypes of diabetic retinopathy in a human inner blood-retinal barrier-on-a-chip10.1038/s41467-024-45456-z ↗
13. Tissue engineering of outer blood retina barrier for therapeutic development10.1016/j.cobme.2024.100538 ↗
14. Photostimulation improves maturation of human photoreceptors
15. Automation of organoid cultures: current protocols and applications, SLAS DISCOVERY: advancing the science of
16. Fda · 2025
17. Organoids-on-a-chip: microfluidic technology enables culture of organoids with enhanced tissue function and potential for disease modeling10.3389/fbioe.2025.1515340 ↗
18. Organoids and organ chips in ophthalmology10.1016/j.jtos.2020.11.004 ↗
19. Merging organoid and organ-on-a-chip technology to generate complex multi-layer tissue models in a human retina-on-a-chip platform10.7554/eLife.46188 ↗
20. Engineering microfluidic organoid-on-a-chip platforms10.3390/mi10030165 ↗
21. Microfluidic organs-on-chips10.1038/nbt.2989 ↗
22. Organ-on-a-chip toxicology
23. Tissue chips–innovative tools for drug development and disease modeling10.1039/C7LC00462A ↗
24. Advances in organ-on-a-chip engineering10.1038/s41578-018-0034-7 ↗
25. The eye and visual nervous system: anatomy, physiology and toxicology10.1289/ehp.82441 ↗
26. Corneal blindness: prevention, treatment and rehabilitation, community
27. Ocular drug delivery: impact of in vitro cell culture models
28. A microengineered human corneal epithelium-on-a-chip for eye drops mass transport evaluation10.1039/C8LC00158H ↗
29. The pathophysiology and treatment of glaucoma: a review10.1001/jama.2014.3192 ↗
30. Human ocular anatomy10.1016/j.clindermatol.2014.10.006 ↗
31. Functional architecture of the retina: development and disease10.1016/j.preteyeres.2014.06.003 ↗
32. The retinal pigment epithelium in visual function10.1152/physrev.00021.2004 ↗
33. The retinal pigment epithelium in health and disease10.2174/156652410793937813 ↗
34. Age‐related macular degeneration—clinical review and genetics update10.1111/cge.12206 ↗
35. Recent developments in age-related macular degeneration: a review10.2147/CIA.S143508 ↗
36. The dynamic nature of Bruch's membrane10.1016/j.preteyeres.2009.08.003 ↗
37. Evaluation of the blood–retinal barrier with optical coherence tomography
38. Cell culture models of the ocular barriers10.1016/j.ejpb.2005.01.009 ↗
39. Fabrication of polymeric biomaterials: a strategy for tissue engineering and medical devices10.1039/C5TB01370D ↗
40. Developmental and pathological angiogenesis10.1146/annurev-cellbio-092910-154002 ↗
41. Microvascular permeability of normal and neoplastic tissues10.1016/0026-2862(86)90018-X ↗
42. Effects of particle geometry for PLGA-based nanoparticles: preparation and in vitro/in vivo evaluation10.3390/pharmaceutics15010175 ↗
43. In vivo imaging of the systemic recruitment of fibroblasts to the angiogenic rim of ovarian carcinoma tumors10.1158/0008-5472.CAN-07-0684 ↗
44. Modeling angiogenesis with micro-and nanotechnology10.1039/C7LC00774D ↗
45. Microfabrication meets microbiology10.1038/nrmicro1616 ↗
46. Microfabrication in biology and medicine10.1146/annurev.bioeng.1.1.401 ↗
47. Zebrafish model in ophthalmology to study disease mechanism and drug discovery10.3390/ph14080716 ↗
48. In vitro models of angiogenesis and vasculogenesis in fibrin gel10.1016/j.yexcr.2013.06.006 ↗
49. Microfluidic co-cultures of retinal pigment epithelial cells and vascular endothelial cells to investigate choroidal angiogenesis10.1038/s41598-017-03788-5 ↗
50. Cell sources and methods for producing organotypic in vitro human tissue models
51. In vitro microvessels for the study of angiogenesis and thrombosis10.1073/pnas.1201240109 ↗
52. Microfluidic organ/body-on-a-chip devices at the convergence of biology and microengineering10.3390/s151229848 ↗
53. The present and future role of microfluidics in biomedical research10.1038/nature13118 ↗
54. Distinct contributions of astrocytes and pericytes to neuroinflammation identified in a 3D human blood-brain barrier on a chip10.1371/journal.pone.0150360 ↗
55. Role of in vitro models for development of ophthalmic delivery systems10.1615/CritRevTherDrugCarrierSyst.2021035222 ↗
56. Is it time to start transitioning from 2D to 3D cell culture?10.3389/fmolb.2020.00033 ↗
57. Altered expression of keratin and vimentin in human retinal pigment epithelial cells in vivo and in vitro10.1002/jcp.1041450202 ↗
58. ARPE-19, a human retinal pigment epithelial cell line with differentiated properties10.1006/exer.1996.0020 ↗
59. Photoreceptor-like cells from reprogramming cultured Mammalian RPE cells
60. Differential protein profiling of primary versus immortalized human RPE cells identifies expression patterns associated with cytoskeletal remodeling and cell survival10.1021/pr050420t ↗
61. R28 retinal precursor cells: the first 20 years
62. Latanoprost rescues retinal neuro-glial cells from apoptosis by inhibiting caspase-3, which is mediated by p44/p42 mitogen-activated protein kinase10.1016/j.exer.2006.05.018 ↗
63. Toxicity of indocyanine green (ICG) in combination with light on retinal pigment epithelial cells and neurosensory retinal cells10.1080/02713680590959312 ↗
64. Recharacterization of the RGC-5 retinal ganglion cell line10.1167/iovs.09-3484 ↗
65. A forensic path to RGC-5 cell line identification: lessons learned10.1167/iovs.13-12085 ↗
66. Beta adrenergic antagonist permeation across cultured rabbit corneal epithelial cells grown on permeable supports10.1076/ceyr.17.2.125.5598 ↗
67. A novel in vivo corneal trans-epithelial electrical resistance measurement device10.1016/j.vascn.2015.08.153 ↗
68. Two clonal cell lines of immortalized human corneal endothelial cells show either differentiated or precursor cell characteristics10.1159/000113406 ↗
69. Mucin gene expression in immortalized human corneal–limbal and conjunctival epithelial cell lines10.1167/iovs.02-0851 ↗
70. Characterization of a spontaneously immortalized cell line (IOBA-NHC) from normal human conjunctiva10.1167/iovs.03-0560 ↗
71. Human immunocompetent choroid-on-chip: a novel tool for studying ocular effects of biological drugs10.1038/s42003-021-02977-3 ↗
72. One-stop assembly of adherent 3D retinal organoids from hiPSCs based on 3D-printed derived PDMS microwell platform10.1088/1758-5090/acc761 ↗
73. Human retinal organoids provide a suitable tool for toxicological investigations: a comprehensive validation using drugs and compounds affecting the retina10.1093/stcltm/szab010 ↗
74. Three-dimensional automated reporter quantification (3D-ARQ) technology enables quantitative screening in retinal organoids10.1242/dev.146290 ↗
75. Discovery of novel selenium derivatives as Pin1 inhibitors by high-throughput screening10.1016/j.bbrc.2016.04.124 ↗
76. High-throughput imaging: focusing in on drug discovery in 3D10.1016/j.ymeth.2015.11.013 ↗
77. Human-induced pluripotent stem cells generate light responsive retinal organoids with variable and nutrient-dependent efficiency10.1002/stem.2883 ↗
78. Application of the organ-on-a-chip technology in experimental ophthalmology, Vestn10.17116/oftalma2023139011114 ↗
79. Optic vesicle-like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment10.1002/stem.674 ↗
80. Self-organizing optic-cup morphogenesis in three-dimensional culture10.1038/nature09941 ↗
81. Wet‐AMD on a chip: modeling outer blood‐retinal barrier in vitro
82. A model microfluidics-based system for the human and mouse retina10.1007/s10544-015-0002-6 ↗
83. Generation of storable retinal organoids and retinal pigmented epithelium from adherent human iPS cells in xeno-free and feeder-free conditions10.1002/stem.2586 ↗
84. Optic vesicle‐like structures derived from human pluripotent stem cells facilitate a customized approach to retinal disease treatment10.1002/stem.674 ↗
85. Reproducibility and staging of 3D human retinal organoids across multiple pluripotent stem cell lines
86. Generation of three-dimensional retinal tissue with functional photoreceptors from human iPSCs10.1038/ncomms5047 ↗
87. Characterization of three-dimensional retinal tissue derived from human embryonic stem cells in adherent monolayer cultures10.1089/scd.2015.0144 ↗
88. Generation of retinal ganglion cells with functional axons from mouse embryonic stem cells and induced pluripotent stem cells10.1167/iovs.16-19166 ↗
89. Modeling glaucoma: retinal ganglion cells generated from induced pluripotent stem cells of patients with SIX6 risk allele show developmental abnormalities10.1002/stem.2675 ↗
90. Self-formation of optic cups and storable stratified neural retina from human ESCs10.1016/j.stem.2012.05.009 ↗
91. Modeling the neurovascular niche: VEGF‐and BDNF‐mediated cross‐talk between neural stem cells and endothelial cells: an in vitro study10.1002/jnr.21087 ↗
92. A macroporous hydrogel for the coculture of neural progenitor and endothelial cells to form functional vascular networks in vivo10.1073/pnas.0506020102 ↗
93. Accelerated and improved differentiation of retinal organoids from pluripotent stem cells in rotating-wall vessel bioreactors10.1016/j.stemcr.2017.11.001 ↗
94. Deciphering retinal diseases through the generation of three dimensional stem cell-derived organoids: concise review10.1002/stem.3089 ↗
95. Organoids and microphysiological systems: new tools for ophthalmic drug discovery10.3389/fphar.2020.00407 ↗
96. Modelling neurodegeneration and inflammation in early diabetic retinopathy using 3D human retinal organoids10.1007/s44164-024-00068-1 ↗
97. Retinal synaptic regeneration via microfluidic guiding channels
98. A model microfluidics-based system for the human and mouse retina10.1007/s10544-015-0002-6 ↗
99. An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris10.1073/pnas.0905010106 ↗
100. Controlled cocultures of HeLa cells and human umbilical vein endothelial cells on detachable substrates10.1039/B812510D ↗